Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Deeth Williams Wall LLP

02 9Gowling WLG (Canada) LLP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Gowling WLG (Canada) LLP

arrow
World Drug Safety EU
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
World Drug Safety EU
Not Confirmed

BUROSUMAB

Brand Name : CRYSVITA

Patent Number : 2677782

Filing Date : 2008-02-14

Strength per Unit : 10 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2028-02-14

Date Granted : 2016-07-26

blank

02

Gowling WLG (Canada) LLP

arrow
World Drug Safety EU
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
World Drug Safety EU
Not Confirmed

BUROSUMAB

Brand Name : CRYSVITA

Patent Number : 2471656

Filing Date : 2003-01-06

Strength per Unit : 10 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2023-01-06

Date Granted : 2012-07-31

blank

03

Deeth Williams Wall LLP

arrow
World Drug Safety EU
Not Confirmed

Deeth Williams Wall LLP

Country
arrow
World Drug Safety EU
Not Confirmed

BUROSUMAB

Brand Name : CRYSVITA

Patent Number : 2418802

Filing Date : 2001-08-10

Strength per Unit : 10 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2021-08-10

Date Granted : 2012-10-23

blank

04

Gowling WLG (Canada) LLP

arrow
World Drug Safety EU
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
World Drug Safety EU
Not Confirmed

BUROSUMAB

Brand Name : CRYSVITA

Patent Number : 2677782

Filing Date : 2008-02-14

Strength per Unit : 20 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2028-02-14

Date Granted : 2016-07-26

blank

05

Gowling WLG (Canada) LLP

arrow
World Drug Safety EU
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
World Drug Safety EU
Not Confirmed

BUROSUMAB

Brand Name : CRYSVITA

Patent Number : 2471656

Filing Date : 2003-01-06

Strength per Unit : 20 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2023-01-06

Date Granted : 2012-07-31

blank

06

Deeth Williams Wall LLP

arrow
World Drug Safety EU
Not Confirmed

Deeth Williams Wall LLP

Country
arrow
World Drug Safety EU
Not Confirmed

BUROSUMAB

Brand Name : CRYSVITA

Patent Number : 2418802

Filing Date : 2001-08-10

Strength per Unit : 20 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2021-08-10

Date Granted : 2012-10-23

blank

07

Gowling WLG (Canada) LLP

arrow
World Drug Safety EU
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
World Drug Safety EU
Not Confirmed

BUROSUMAB

Brand Name : CRYSVITA

Patent Number : 2677782

Filing Date : 2008-02-14

Strength per Unit : 30 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2028-02-14

Date Granted : 2016-07-26

blank

08

Gowling WLG (Canada) LLP

arrow
World Drug Safety EU
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
World Drug Safety EU
Not Confirmed

BUROSUMAB

Brand Name : CRYSVITA

Patent Number : 2471656

Filing Date : 2003-01-06

Strength per Unit : 30 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2023-01-06

Date Granted : 2012-07-31

blank

09

Deeth Williams Wall LLP

arrow
World Drug Safety EU
Not Confirmed

Deeth Williams Wall LLP

Country
arrow
World Drug Safety EU
Not Confirmed

BUROSUMAB

Brand Name : CRYSVITA

Patent Number : 2418802

Filing Date : 2001-08-10

Strength per Unit : 30 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2021-08-10

Date Granted : 2012-10-23

blank

10

Gowling WLG (Canada) LLP

arrow
World Drug Safety EU
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
World Drug Safety EU
Not Confirmed

BUROSUMAB

Brand Name : CRYSVITA

Patent Number : 2949234

Filing Date : 2015-05-29

Strength per Unit : 10 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2035-05-29

Date Granted : 2022-03-22

blank